David Young - 07 Feb 2024 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
07 Feb 2024
Transactions value $
$51,526
Form type
4
Filing time
08 Feb 2024, 16:30:43 UTC
Previous filing
07 Feb 2024
Next filing
02 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Purchase $51,525 +21,000 +35.97% $2.45 79,387 07 Feb 2024 Direct
holding PCSA Common Stock 30,985 07 Feb 2024 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 10,786 07 Feb 2024 By Family Entities
holding PCSA Common Stock 18,544 07 Feb 2024 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.